Advancing the Cholangiocarcinoma & Myeloid Lymphoid Neoplasm Patient Journey
Advancing the Cholangiocarcinoma & Myeloid Lymphoid Neoplasm Patient Journey
Flavio Rocha
How to Incorporate Molecular Testing in Therapy for Localized Cholangiocarcinoma
- 163 views
- March 18, 2024
Milind Javle
Importance of Molecular Profiling in Biliary Tract Cancer
- 198 views
- February 10, 2023
- 1
Moffitt Cancer Center
Real-World Characteristics, Treatment Patterns, and Outcomes of Patients With Cholangiocarcinoma Treated With Pemigatinib
FEATURING
Richard Kim
- 132 views
- February 27, 2024
- 1
Moffitt Cancer Center
Real-World Use of Pemigatinib for Cholangiocarcinoma Among Racial and Ethnic Minorities in The United States
FEATURING
Richard Kim
- 93 views
- February 27, 2024
ASH 2022 Conference Coverage
Phase 2 FIGHT-203 Study: Pemigatinib in Pts With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement
FEATURING
Alessandro Vannucchi
- 408 views
- February 14, 2023
- 1
Scripps MD Anderson Cancer Center
What’s New: Oncology Drug Updates - Part 2
FEATURING
Bryan Do
- 69 views
- November 10, 2023
Moffitt Cancer Center
Year in Review: Hepatobiliary Cancers
FEATURING
Richard Kim,
Tiago Biachi
- 528 views
- December 22, 2023
- 4
Insights from 2023 ESMO Annual Meeting
Personalized Medicine and Targeted Agents for Biliary Tract Cancer
FEATURING
Lorenza Rimassa
- 420 views
- October 28, 2023
- 3
